This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2014 May 1;14(5):858-9.

doi: 10.1016/j.spinee.2013.10.033. Epub 2013 Nov 8.

Interaction of potential risk factors for cancer

Emily Jane Woo¹

Affiliations

PMID: 24216401
DOI: 10.1016/j.spinee.2013.10.033

Comment

Interaction of potential risk factors for cancer

Emily Jane Woo. Spine J. 2014.

. 2014 May 1;14(5):858-9.

doi: 10.1016/j.spinee.2013.10.033. Epub 2013 Nov 8.

Author

Emily Jane Woo¹

Affiliation

¹ US Food and Drug Administration, HFM-222, 1401 Rockville Pike, Rockville, MD 20852, USA.

PMID: 24216401
DOI: 10.1016/j.spinee.2013.10.033

No abstract available

PubMed Disclaimer

Comment on

Cancer risk after use of recombinant bone morphogenetic protein-2 for spinal arthrodesis.
Carragee EJ, Chu G, Rohatgi R, Hurwitz EL, Weiner BK, Yoon ST, Comer G, Kopjar B. Carragee EJ, et al. J Bone Joint Surg Am. 2013 Sep 4;95(17):1537-45. doi: 10.2106/JBJS.L.01483. J Bone Joint Surg Am. 2013. PMID: 24005193

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information